[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 54.197.124.106. Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Views 153
Citations 0
Comment & Response
October 2016

Prescription Trends—Brand-name Drugs vs Generic

Author Affiliations
  • 1University of Chicago Pritzker School of Medicine, Chicago, Illinois
  • 2University of Chicago Medicine, Chicago, Illinois
  • 3Department of Medicine, Univeristy of Chicago, Chicago, Illinois
JAMA Intern Med. 2016;176(10):1573-1574. doi:10.1001/jamainternmed.2016.5375

To the Editor In a recent issue of JAMA Internal Medicine, Dr Kesselheim and colleagues1 reported national survey results of physicians’ perceptions of generic drugs and how they learned about newly available generic drugs. While their data show increasing physician confidence in the safety and efficacy of generic drugs, they also found that generic skepticism is still common (32% of participants) and physicians do not know when generic drugs they commonly prescribe become available (50% of participants answered “sometimes,” “rarely,” or “never”). We agree with the authors that limiting interactions with pharmaceutical marketing and directed educational outreach about generic drugs are both needed.

First Page Preview View Large
First page PDF preview
First page PDF preview
×